US pediatric injuries involving amusement rides, 1990-2010

Meghan C Thompson1, Thiphalak Chounthirath, Huiyun Xiang

  • 1Center for Injury Research and policy, The Research Institute at Nationwide Children's Hospital, 700 Children’s Drive, Columbus, OH 43205, USA.

Insights

Over 92,000 children sustained amusement ride injuries in US emergency departments from 1990-2010. Falls were the most common cause, highlighting a need for improved ride safety for pediatric patients.

Area of Science:

  • Pediatric Emergency Medicine
  • Public Health Surveillance
  • Injury Prevention Science

Background:

  • Amusement rides are a common source of pediatric injuries.
  • Understanding injury patterns is crucial for developing effective safety measures.
  • Existing surveillance systems may not fully capture the scope of amusement ride-related incidents.

Purpose of the Study:

  • To investigate the epidemiology of pediatric injuries associated with amusement rides treated in US emergency departments.
  • To identify common injury types, body regions, and mechanisms.
  • To assess the need for enhanced national injury surveillance for amusement rides.

Main Methods:

  • Retrospective analysis of data from the National Electronic Injury Surveillance System (NEISS).
  • Inclusion of pediatric patients (≤17 years) treated for amusement ride-related injuries between 1990 and 2010.
  • Calculation of injury rates, demographic characteristics, injury types, and mechanisms.

Main Results:

  • An estimated 92,885 children (average 4,423 annually) were treated for amusement ride injuries.
  • The head and neck (28.0%) were most commonly injured; soft tissue injuries (29.4%) predominated.
  • Falls (31.7%) were the leading cause of injury, with a low hospitalization rate (1.5%).

Conclusions:

  • Pediatric amusement ride injuries are a significant public health concern, with falls being a primary mechanism.
  • Current data suggest opportunities exist to enhance amusement ride safety for children.
  • Improved national injury surveillance is recommended to better monitor and prevent these incidents.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...